Report cover image

Global Nicotinamide Tablets Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 190 Pages
SKU # APRC20360561

Description

Summary

According to APO Research, the global Nicotinamide Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Nicotinamide Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Nicotinamide Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Nicotinamide Tablets market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Nicotinamide Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Nicotinamide Tablets market include Puritan’s Pride, Swisse, CONBA, Shanghai Pharma, Century Huaxing Biological Engineering and Tianjin Lisheng Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nicotinamide Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Nicotinamide Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Nicotinamide Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nicotinamide Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Nicotinamide Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Nicotinamide Tablets sales, projected growth trends, production technology, application and end-user industry.

Nicotinamide Tablets Segment by Company

Puritan’s Pride
Swisse
CONBA
Shanghai Pharma
Century Huaxing Biological Engineering
Tianjin Lisheng Pharmaceutical
Nicotinamide Tablets Segment by Type

50mg/Tablets
100mg/Tablets
Nicotinamide Tablets Segment by Application

Online Sales
Offline Sales
Nicotinamide Tablets Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Nicotinamide Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Nicotinamide Tablets market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Nicotinamide Tablets significant trends, drivers, influence factors in global and regions.
6. To analyze Nicotinamide Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicotinamide Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nicotinamide Tablets industry.
Chapter 3: Detailed analysis of Nicotinamide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Nicotinamide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Nicotinamide Tablets in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Nicotinamide Tablets Sales Value (2020-2031)
1.2.2 Global Nicotinamide Tablets Sales Volume (2020-2031)
1.2.3 Global Nicotinamide Tablets Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Nicotinamide Tablets Market Dynamics
2.1 Nicotinamide Tablets Industry Trends
2.2 Nicotinamide Tablets Industry Drivers
2.3 Nicotinamide Tablets Industry Opportunities and Challenges
2.4 Nicotinamide Tablets Industry Restraints
3 Nicotinamide Tablets Market by Company
3.1 Global Nicotinamide Tablets Company Revenue Ranking in 2024
3.2 Global Nicotinamide Tablets Revenue by Company (2020-2025)
3.3 Global Nicotinamide Tablets Sales Volume by Company (2020-2025)
3.4 Global Nicotinamide Tablets Average Price by Company (2020-2025)
3.5 Global Nicotinamide Tablets Company Ranking (2023-2025)
3.6 Global Nicotinamide Tablets Company Manufacturing Base and Headquarters
3.7 Global Nicotinamide Tablets Company Product Type and Application
3.8 Global Nicotinamide Tablets Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Nicotinamide Tablets Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Nicotinamide Tablets Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Nicotinamide Tablets Market by Type
4.1 Nicotinamide Tablets Type Introduction
4.1.1 50mg/Tablets
4.1.2 100mg/Tablets
4.2 Global Nicotinamide Tablets Sales Volume by Type
4.2.1 Global Nicotinamide Tablets Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Nicotinamide Tablets Sales Volume by Type (2020-2031)
4.2.3 Global Nicotinamide Tablets Sales Volume Share by Type (2020-2031)
4.3 Global Nicotinamide Tablets Sales Value by Type
4.3.1 Global Nicotinamide Tablets Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Nicotinamide Tablets Sales Value by Type (2020-2031)
4.3.3 Global Nicotinamide Tablets Sales Value Share by Type (2020-2031)
5 Nicotinamide Tablets Market by Application
5.1 Nicotinamide Tablets Application Introduction
5.1.1 Online Sales
5.1.2 Offline Sales
5.2 Global Nicotinamide Tablets Sales Volume by Application
5.2.1 Global Nicotinamide Tablets Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Nicotinamide Tablets Sales Volume by Application (2020-2031)
5.2.3 Global Nicotinamide Tablets Sales Volume Share by Application (2020-2031)
5.3 Global Nicotinamide Tablets Sales Value by Application
5.3.1 Global Nicotinamide Tablets Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Nicotinamide Tablets Sales Value by Application (2020-2031)
5.3.3 Global Nicotinamide Tablets Sales Value Share by Application (2020-2031)
6 Nicotinamide Tablets Regional Sales and Value Analysis
6.1 Global Nicotinamide Tablets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Nicotinamide Tablets Sales by Region (2020-2031)
6.2.1 Global Nicotinamide Tablets Sales by Region: 2020-2025
6.2.2 Global Nicotinamide Tablets Sales by Region (2026-2031)
6.3 Global Nicotinamide Tablets Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Nicotinamide Tablets Sales Value by Region (2020-2031)
6.4.1 Global Nicotinamide Tablets Sales Value by Region: 2020-2025
6.4.2 Global Nicotinamide Tablets Sales Value by Region (2026-2031)
6.5 Global Nicotinamide Tablets Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Nicotinamide Tablets Sales Value (2020-2031)
6.6.2 North America Nicotinamide Tablets Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Nicotinamide Tablets Sales Value (2020-2031)
6.7.2 Europe Nicotinamide Tablets Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Nicotinamide Tablets Sales Value (2020-2031)
6.8.2 Asia-Pacific Nicotinamide Tablets Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Nicotinamide Tablets Sales Value (2020-2031)
6.9.2 South America Nicotinamide Tablets Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Nicotinamide Tablets Sales Value (2020-2031)
6.10.2 Middle East & Africa Nicotinamide Tablets Sales Value Share by Country, 2024 VS 2031
7 Nicotinamide Tablets Country-level Sales and Value Analysis
7.1 Global Nicotinamide Tablets Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Nicotinamide Tablets Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Nicotinamide Tablets Sales by Country (2020-2031)
7.3.1 Global Nicotinamide Tablets Sales by Country (2020-2025)
7.3.2 Global Nicotinamide Tablets Sales by Country (2026-2031)
7.4 Global Nicotinamide Tablets Sales Value by Country (2020-2031)
7.4.1 Global Nicotinamide Tablets Sales Value by Country (2020-2025)
7.4.2 Global Nicotinamide Tablets Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.5.2 USA Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.6.2 Canada Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.8.2 Germany Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.9.2 France Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.9.3 France Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.11.2 Italy Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.12.2 Spain Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.13.2 Russia Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.16.2 China Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.16.3 China Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.17.2 Japan Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.19.2 India Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.19.3 India Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.20.2 Australia Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.24.2 Chile Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.26.2 Peru Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.28.2 Israel Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.29.2 UAE Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.31.2 Iran Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Nicotinamide Tablets Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Nicotinamide Tablets Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Nicotinamide Tablets Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Puritan’s Pride
8.1.1 Puritan’s Pride Comapny Information
8.1.2 Puritan’s Pride Business Overview
8.1.3 Puritan’s Pride Nicotinamide Tablets Sales, Value and Gross Margin (2020-2025)
8.1.4 Puritan’s Pride Nicotinamide Tablets Product Portfolio
8.1.5 Puritan’s Pride Recent Developments
8.2 Swisse
8.2.1 Swisse Comapny Information
8.2.2 Swisse Business Overview
8.2.3 Swisse Nicotinamide Tablets Sales, Value and Gross Margin (2020-2025)
8.2.4 Swisse Nicotinamide Tablets Product Portfolio
8.2.5 Swisse Recent Developments
8.3 CONBA
8.3.1 CONBA Comapny Information
8.3.2 CONBA Business Overview
8.3.3 CONBA Nicotinamide Tablets Sales, Value and Gross Margin (2020-2025)
8.3.4 CONBA Nicotinamide Tablets Product Portfolio
8.3.5 CONBA Recent Developments
8.4 Shanghai Pharma
8.4.1 Shanghai Pharma Comapny Information
8.4.2 Shanghai Pharma Business Overview
8.4.3 Shanghai Pharma Nicotinamide Tablets Sales, Value and Gross Margin (2020-2025)
8.4.4 Shanghai Pharma Nicotinamide Tablets Product Portfolio
8.4.5 Shanghai Pharma Recent Developments
8.5 Century Huaxing Biological Engineering
8.5.1 Century Huaxing Biological Engineering Comapny Information
8.5.2 Century Huaxing Biological Engineering Business Overview
8.5.3 Century Huaxing Biological Engineering Nicotinamide Tablets Sales, Value and Gross Margin (2020-2025)
8.5.4 Century Huaxing Biological Engineering Nicotinamide Tablets Product Portfolio
8.5.5 Century Huaxing Biological Engineering Recent Developments
8.6 Tianjin Lisheng Pharmaceutical
8.6.1 Tianjin Lisheng Pharmaceutical Comapny Information
8.6.2 Tianjin Lisheng Pharmaceutical Business Overview
8.6.3 Tianjin Lisheng Pharmaceutical Nicotinamide Tablets Sales, Value and Gross Margin (2020-2025)
8.6.4 Tianjin Lisheng Pharmaceutical Nicotinamide Tablets Product Portfolio
8.6.5 Tianjin Lisheng Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Nicotinamide Tablets Value Chain Analysis
9.1.1 Nicotinamide Tablets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Nicotinamide Tablets Sales Mode & Process
9.2 Nicotinamide Tablets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Nicotinamide Tablets Distributors
9.2.3 Nicotinamide Tablets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.